Ifp Advisors, Inc Enanta Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$41.02 - $58.65 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$43.76 - $53.11 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$41.69 - $54.95 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$41.16 - $47.47 $10,660 - $12,294	-259 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$43.36 - $53.53 $11,230 - $13,864	259 New	259 $11,000
Q2 2020 Aug 05, 2020	BUY	$46.37 - $57.58 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$40.22 - $62.0 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$57.95 - $66.61 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$60.08 - $88.17 $0 - $0	0 New	0 $0
Q4 2018 Jan 23, 2019	SELL	$65.41 - $84.65 $8,895 - $11,512	-136 Closed	0 $0
Q1 2017 Jun 03, 2019	SELL	N/A	-175 Reduced 56.27%	136 $4,000
Q4 2016 Jun 03, 2019	SELL	N/A	-1,340 Reduced 81.16%	311 $10,000
Q2 2016 Jun 03, 2019	BUY	N/A	1,651	1,651 $36,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.